Key stats
About NOVOMICS
Sector
Industry
Headquarters
Seoul
Website
Founded
2010
ISIN
KR7283100006
FIGI
BBG01G8G6HF9
Novomics Co., Ltd. engages in natural science and engineering research and development. It analyzes life sciences such as the cancer genome. The company was founded on March 4, 2010 and is headquartered in Seoul, South Korea.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 283100 is 777 KRW — it hasn't changed in the past 24 hours. Watch NOVOMICS stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange NOVOMICS stocks are traded under the ticker 283100.
283100 stock has risen by 29.50% compared to the previous week, the month change is a 37.77% rise, over the last year NOVOMICS has showed a −72.83% decrease.
283100 reached its all-time high on Apr 19, 2023 with the price of 9,000 KRW, and its all-time low was 375 KRW and was reached on Aug 7, 2024. View more price dynamics on 283100 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
283100 stock is 19.23% volatile and has beta coefficient of 0.57. Track NOVOMICS stock price on the chart and check out the list of the most volatile stocks — is NOVOMICS there?
No, 283100 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 283100 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade NOVOMICS stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So NOVOMICS technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating NOVOMICS stock shows the buy signal. See more of NOVOMICS technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.